{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:32Z","timestamp":1793890532717,"version":"4.8.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T00:00:00Z","timestamp":1364342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-158","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T03:14:19Z","timestamp":1364354059000},"source":"Crossref","is-referenced-by-count":338,"title":["Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review"],"prefix":"10.1186","volume":"13","author":[{"given":"Syed H","family":"Jafri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,27]]},"reference":[{"key":"3777_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics 2012. CA Cancer J Clin. 2012, 62: 10-29. 10.3322\/caac.20138.","journal-title":"CA Cancer J Clin"},{"key":"3777_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1056\/NEJMra0802714","volume":"359","author":"R Herbst","year":"2008","unstructured":"Herbst R, Heymach J, Lippman S: Lung cancer. NEJM. 2008, 359: 1367-1380. 10.1056\/NEJMra0802714.","journal-title":"NEJM"},{"key":"3777_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.anndiagpath.2006.04.006","volume":"11","author":"M Wabah","year":"2007","unstructured":"Wabah M, Boroumand N, Castro C: Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol. 2007, 11: 89-96. 10.1016\/j.anndiagpath.2006.04.006.","journal-title":"Ann Diagn Pathol"},{"key":"3777_CR4","volume-title":"SEER Cancer Statistics Review 1975\u20132009 (Vintage: Populations)","author":"N Howlader","year":"2009","unstructured":"Howlader N, Noone AM, Krapcho M: SEER Cancer Statistics Review 1975\u20132009 (Vintage: Populations). 2009, Bethesda, MD: National Cancer Institute,"},{"issue":"24","key":"3777_CR5","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Gray R, Perry M: Paclitaxel-carboplatin alone or with bevacizumab in non-small cell lung cancer. NEJM. 2006, 355 (24): 2542-2550. 10.1056\/NEJMoa061884.","journal-title":"NEJM"},{"key":"3777_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A: Cancer related Inflammation. Nature. 2008, 454: 436-444. 10.1038\/nature07205.","journal-title":"Nature"},{"key":"3777_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg R: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"4","key":"3777_CR8","first-page":"157","volume":"5","author":"N McDonald","year":"2007","unstructured":"McDonald N: Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative\/supportive care. Supportive oncology. 2007, 5 (4): 157-162.","journal-title":"Supportive oncology"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/bjc.2011.100","volume":"104","author":"W Chua","year":"2011","unstructured":"Chua W, Charles KA, Clarke SJ: Neutrophil\/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer. 2011, 104: 1288-1295. 10.1038\/bjc.2011.100.","journal-title":"Br J Cancer"},{"issue":"1","key":"3777_CR10","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec R: Ratio of neutrophil to lymphocyte counts\u2014rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listv. 2001, 102 (1): 5-14.","journal-title":"Bratisl Lek Listv"},{"issue":"2","key":"3777_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","volume":"137","author":"KM Sarraf","year":"2008","unstructured":"Sarraf KM, Belcher E, Raevsky E: Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2008, 137 (2): 425-428.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3777_CR12","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","volume":"121","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Harris CC: Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007, 121: 2373-2380. 10.1002\/ijc.23173.","journal-title":"Int J Cancer"},{"key":"3777_CR13","volume-title":"Rheumatol Int","author":"F Ismail","year":"2012","unstructured":"Ismail F, Mahmoud A, Abdelhaleem H: Primary Sjogren\u2019s syndrome and B-non-Hodgkins lymphoma: role of CD4+ T lymphocytopenia. Rheumatol Int. 2012, Epub ahead of print"},{"issue":"16","key":"3777_CR14","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1200\/JCO.2009.27.0454","volume":"28","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK, Caporaso NE, Ktaki HA: C-reactive protein and risk of lung cancer. JCO. 2010, 28 (16): 2719-2726. 10.1200\/JCO.2009.27.0454.","journal-title":"JCO"},{"issue":"8","key":"3777_CR15","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9","volume":"15:75","author":"JS Falconer","year":"1995","unstructured":"Falconer JS, Fearon KC, Ross JA: Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer. 1995, 15:75 (8): 2077-2082.","journal-title":"Cancer"},{"key":"3777_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","volume":"89","author":"LM Forrest","year":"2003","unstructured":"Forrest LM, Mcmillan DC, McArdle CS: Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small cell lung cancer. BJC. 2003, 89: 1028-1030. 10.1038\/sj.bjc.6601242.","journal-title":"BJC"},{"key":"3777_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.bjc.6600466","volume":"87","author":"HR Scott","year":"2002","unstructured":"Scott HR, McMillan DC, Forrest LM: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. BJC. 2002, 87: 264-267. 10.1038\/sj.bjc.6600466.","journal-title":"BJC"},{"issue":"32","key":"3777_CR18","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1200\/JCO.2011.35.5214","volume":"29","author":"JM Harry","year":"2011","unstructured":"Harry JM, Sietsma H, Vincent A: Randomized, placebo controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase \u22122 expression as a biomarker for patients with advanced non-small cell lung cancer: The NVALT-4 study. JCO. 2011, 29 (32): 4320-4432. 10.1200\/JCO.2011.35.5214.","journal-title":"JCO"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-158\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T15:44:36Z","timestamp":1468338276000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-158","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]},"article-number":"158"}}